Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Trading Statement

12 Nov 2024 07:00

RNS Number : 7756L
4imprint Group PLC
12 November 2024
 

12 November 2024

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

4imprint today provides a scheduled update on the Group's trading and operations.

 

The Group has delivered a strong financial performance in difficult market conditions in the 10 month period up to the end of October 2024.

 

The Board is pleased to update the full year 2024 financial guidance given with the Interim results on 7 August 2024. Expectations for Group profit before tax remain unchanged and are within the current range of analysts' forecasts at just over $150m. Group revenue is expected to be around $1.37bn.

 

October year to date total order count was 2% higher than prior year. New customer orders were 9% below prior year to date, but encouragingly existing customer orders were up 6%, reflecting the quality of customers acquired under the new marketing mix. Combined with strong average order values at 2% above prior year, overall order revenue was 4% above the same time period in 2023.

 

The promotional products industry in our primary North American market has continued to present a challenging trading backdrop. Continuing uncertainty around economic conditions has translated into generally weaker levels of corporate confidence, compounded by specific macro factors over which the Group has no control, including elevated interest rates, severe weather events and the distraction arising from the US election cycle.

 

Although these factors have resulted in some pressure on revenue, performance across the remainder of the business has been very satisfactory. In particular, gross profit margin has remained strong at around 32% and the resilience and flexibility of the new marketing mix has enabled us to be agile in tailoring our marketing investment to the prevailing market conditions. The resulting double digit operating profit margin is a key factor underpinning our Group profit before tax performance.

 

With a cash balance of $137m at the end of October 2024, the Group remains highly cash generative and well financed.

 

Our experience is that less buoyant economic conditions represent a market share opportunity for 4imprint as our financial strength allows us to keep investing in the business and to take full advantage of the market recovery when it arrives.

 

The Board remains very confident in the Group's strategy, positioning and prospects.

 

 

For further information, please contact:

 

4imprint Group plc

MHP Group

Tel: + 44 (0) 20 3709 9680

Tel: + 44 (0) 7884 494112

Kevin Lyons-Tarr, Chief Executive Officer

Katie Hunt

David Seekings, Chief Financial Officer

Eleni Menikou

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDFLFFZFLBFBX
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.